Utah Code 26B-5-505. Proceeding for essential treatment — Duties of court — Disposition
Current as of: 2023 | Check for updates
|
Other versions
26B-5-505. Proceeding for essential treatment — Duties of court — Disposition.
(1) | A court shall review the assertions contained in the verified petition described in Section 26B-5-503. |
(a) | a licensed physician, preferably a psychiatrist, who is designated by the division as specifically qualified by training or experience in the diagnosis of substance use disorder; or |
(b) | a licensed mental health professional designated by the division as specially qualified by training and who has at least five years' continual experience in the treatment of substance use disorder. See Utah Code 26B-5-501 | ||||||||||||||||||||
(2) | If the court determines that the assertions, if true, are sufficient to order the respondent to undergo essential treatment, the court shall:
|
(3) | An essential treatment examiner shall examine the respondent to determine:
|
(4) | An essential treatment examiner shall certify the examiner’s findings to the court within 24 hours after completion of the examination. |
(5) | The court may, based upon the findings of an essential treatment examiner, terminate the proceedings and dismiss the petition. |
(6) | The parties may, at any time, make a binding stipulation to an essential treatment plan and submit that plan to the court for court order. |
(7) | At the hearing, the petitioner and the respondent may testify and may cross-examine witnesses. |
(8) | If, upon completion of the hearing, the court finds that the criteria in Section 26B-5-504 are met, the court shall order essential treatment for an initial period that:
|
(9) | The court shall designate the facility for the essential treatment, as:
|
(10) | The court shall issue an order that includes the court’s findings and the reasons for the court’s determination. |
(11) | The court may order the petitioner to be the respondent’s personal representative, as described in 45 C.F.R. § 164.502(g), for purposes of the respondent’s essential treatment. |
Renumbered and Amended by Chapter 308, 2023 General Session